Evidence map›Paper›PMID 42732210›Full record

ArticleClinical case reports2026

Pancreatitis and Myocardial Infarction as Complications of Thrombotic Thrombocytopenic Purpura: A Case Report.

Farid Poursadegh, Motahhareh Karimoddini, Mohsen Seddigh-Shamsi, Najme Mohajer

Abstract read
In one paragraph

Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Farid PoursadeghLung Disease Research Center Mashhad University of Medical Sciences Mashhad Iran.
Motahhareh KarimoddiniInternal Medicine Department, Faculty of Medicine Mashhad University of Medical Sciences Mashhad Iran.ORCID https://orcid.org/0009-0003-9094-6069
Mohsen Seddigh-ShamsiDepartment of Hematology- Oncology, Faculty of Medicine Mashhad University of Medical Sciences Mashhad Iran.
Najme MohajerResident of Internal Medicine Mashhad University of Medical Sciences Mashhad Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thrombotic thrombocytopenic purpura (TTP) is a rare disease with a mortality rate of 90% if not treated promptly. Due to limited clinical experience and sometimes atypical presentation, early detection of TTP is not always easy. The pathophysiological mechanisms underlying TTP can accelerate thrombus formation and vascular occlusion, potentially leading to ischemic damage in various organs, including the heart and pancreas. Considering that the complications caused by these disorders can be life-threatening, the simultaneous manifestation of acute pancreatitis (AP), TTP, and heart damage in the patient may cause a significant risk of mortality if not treated in time and adequately. We report a case involving a 43-year-old patient who presented with symptoms of myocardial infarction (MI) and acute pancreatitis (AP) secondary to thrombotic thrombocytopenic purpura (TTP). The patient was diagnosed based on clinical manifestations, laboratory findings, and imaging studies. Immediate intervention included plasma exchange and supportive care, which led to the stabilization of the patient's condition. This case highlights the importance of actively assessing and monitoring for organ involvement, including pancreatic and cardiac complications, in patients with TTP. Early diagnosis and prompt treatment are critical in reducing the risk of mortality associated with these severe complications.

Indexed as

acute pancreatitis (AP)ADAMTS13myocardial infarction (MI)plasma exchangethrombocytopeniathrombotic thrombocytopenic purpura (TTP)

Identifiers

PMID42732210
PMCPMC13569877

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.